Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (10,000,339) $ (13,730,580)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 1,077,070 1,474,298
Amortization of intangible assets 181,751 181,751
Amortization of debt issuance costs 164,103 222,666
Amortization of debt discount   880,623
Amortization of debt premium 20,834  
Amortization of right-of-use asset 422,254 297,129
Loss on extinguishment of debt 334,511 0
Gain on disposal of fixed assets   (9,705)
Reserve for credit losses 179,071 199,145
Stock based compensation expense 738,336 947,757
Change in fair value of Private Warrants 0 (19,835)
Changes in operating assets and liabilities:    
Accounts receivable (942,795) (756,175)
Inventory 319,648 1,985,275
Prepaid expenses and other current assets 6,873 533,386
Accounts payable 2,038,755 961,482
Accrued liabilities 703,813 679,693
Operating lease obligations (378,836) (244,302)
Net cash used in operating activities (5,134,951) (6,397,391)
CASH FLOWS FROM INVESTING ACTIVITIES    
Cash paid for purchase of equipment (27,246) (150,297)
Cash received for sale of equipment   11,000
Net cash used in investing activities (27,246) (139,297)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from the issuance of common stock, net 711,031 1,016,088
Repayments on long-term debt (116,084) (120,643)
Borrowings on related party debt 2,435,000 1,175,000
Borrowings on short-term debt 16,257,558 16,555,768
Repayments on short-term debt (14,186,264) (12,268,986)
Debt issuance costs (55,630) (176,287)
Deferred offering costs (69,166) (38,622)
Payments in lieu of fractional shares in connection with the reverse stock split   (2,318)
Net cash provided by financing activities 4,976,445 6,140,000
Net change in cash and cash equivalents (185,752) (396,688)
Cash and cash equivalents at beginning of period 369,114 623,163
Cash and cash equivalents at end of period 183,362 226,475
SUPPLEMENTAL INFORMATION:    
Cash paid for interest 1,363,648 1,160,466
NON-CASH INVESTING AND FINANCING ACTIVITY:    
Non-cash commercial premium finance borrowing 394,145 843,127
Issuance of warrants in connection with debt instrument   $ 1,374,631
Common stock issued for accrued expenses 147,287  
Common stock issued for accrued expenses - related party 100,000  
Accrued fixed assets $ 78,501